Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.

Lim J, Crespo-Barreto J, Jafar-Nejad P, Bowman AB, Richman R, Hill DE, Orr HT, Zoghbi HY
Nature. 2008 452 (7188): 713-8

PMID: 18337722 · PMCID: PMC2377396 · DOI:10.1038/nature06731

Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease caused by expansion of a glutamine-encoding repeat in ataxin 1 (ATXN1). In all known polyglutamine diseases, the glutamine expansion confers toxic functions onto the protein; however, the mechanism by which this occurs remains enigmatic, in light of the fact that the mutant protein apparently maintains interactions with its usual partners. Here we show that the expanded polyglutamine tract differentially affects the function of the host protein in the context of different endogenous protein complexes. Polyglutamine expansion in ATXN1 favours the formation of a particular protein complex containing RBM17, contributing to SCA1 neuropathology by means of a gain-of-function mechanism. Concomitantly, polyglutamine expansion attenuates the formation and function of another protein complex containing ATXN1 and capicua, contributing to SCA1 through a partial loss-of-function mechanism. This model provides mechanistic insight into the molecular pathogenesis of SCA1 as well as other polyglutamine diseases.

MeSH Terms (23)

Alleles Animals Ataxin-1 Ataxins Drosophila melanogaster Drosophila Proteins Humans Mice Multiprotein Complexes Nerve Tissue Proteins Nuclear Proteins Open Reading Frames Peptides Protein Binding Protein Structure, Quaternary Purkinje Cells Repressor Proteins Ribonucleoprotein, U2 Small Nuclear RNA-Binding Proteins RNA Splicing Factors Spinocerebellar Ataxias Trinucleotide Repeat Expansion Two-Hybrid System Techniques

Connections (2)

This publication is referenced by other Labnodes entities: